TWI623499B - Bioremediation preparation for mercuric pollution and using method thereof - Google Patents
Bioremediation preparation for mercuric pollution and using method thereof Download PDFInfo
- Publication number
- TWI623499B TWI623499B TW103101413A TW103101413A TWI623499B TW I623499 B TWI623499 B TW I623499B TW 103101413 A TW103101413 A TW 103101413A TW 103101413 A TW103101413 A TW 103101413A TW I623499 B TWI623499 B TW I623499B
- Authority
- TW
- Taiwan
- Prior art keywords
- mercury
- contaminated
- pseudomonas
- strain
- bioremediation
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims description 32
- 229910052753 mercury Inorganic materials 0.000 claims abstract description 169
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims abstract description 145
- 230000012010 growth Effects 0.000 claims abstract description 56
- 239000002689 soil Substances 0.000 claims abstract description 35
- 241000589516 Pseudomonas Species 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 241000588697 Enterobacter cloacae Species 0.000 claims abstract description 15
- 238000005067 remediation Methods 0.000 claims abstract description 14
- 239000013535 sea water Substances 0.000 claims abstract description 12
- 241001444567 Pseudomonas sp. A45 Species 0.000 claims abstract description 6
- 241001467169 Pseudomonas sp. A46 Species 0.000 claims abstract description 6
- 239000002351 wastewater Substances 0.000 claims description 11
- 238000011161 development Methods 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000010802 sludge Substances 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000011160 research Methods 0.000 claims description 5
- 239000003673 groundwater Substances 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 239000013049 sediment Substances 0.000 claims description 3
- 241000588914 Enterobacter Species 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 abstract description 8
- 231100001231 less toxic Toxicity 0.000 abstract description 4
- 238000011065 in-situ storage Methods 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 description 43
- -1 mercury ions Chemical class 0.000 description 35
- 239000002609 medium Substances 0.000 description 28
- 101150054612 merA gene Proteins 0.000 description 28
- 238000012360 testing method Methods 0.000 description 28
- 150000003839 salts Chemical class 0.000 description 26
- 238000002835 absorbance Methods 0.000 description 23
- 239000000243 solution Substances 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 19
- 230000003698 anagen phase Effects 0.000 description 14
- 108020004465 16S ribosomal RNA Proteins 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 230000015784 hyperosmotic salinity response Effects 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 230000003111 delayed effect Effects 0.000 description 7
- BQPIGGFYSBELGY-UHFFFAOYSA-N mercury(2+) Chemical compound [Hg+2] BQPIGGFYSBELGY-UHFFFAOYSA-N 0.000 description 7
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- 229910052801 chlorine Inorganic materials 0.000 description 6
- 108010056360 mercuric reductase Proteins 0.000 description 6
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 6
- 230000002441 reversible effect Effects 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 5
- 238000011109 contamination Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 108090000854 Oxidoreductases Proteins 0.000 description 4
- 241000589774 Pseudomonas sp. Species 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229960002523 mercuric chloride Drugs 0.000 description 4
- 150000002731 mercury compounds Chemical class 0.000 description 4
- 210000002706 plastid Anatomy 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000010865 sewage Substances 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 229910000497 Amalgam Inorganic materials 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 239000003344 environmental pollutant Substances 0.000 description 3
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 231100000719 pollutant Toxicity 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 229910052979 sodium sulfide Inorganic materials 0.000 description 3
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 241000589776 Pseudomonas putida Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 238000005868 electrolysis reaction Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 101150014096 merP gene Proteins 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachlorophenol Chemical compound OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- QXKXDIKCIPXUPL-UHFFFAOYSA-N sulfanylidenemercury Chemical compound [Hg]=S QXKXDIKCIPXUPL-UHFFFAOYSA-N 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- OCUSNPIJIZCRSZ-ZTZWCFDHSA-N (2s)-2-amino-3-methylbutanoic acid;(2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O OCUSNPIJIZCRSZ-ZTZWCFDHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 101100237157 Bacillus cereus merB1 gene Proteins 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000137060 Enterobacter cloacae subsp. cloacae ATCC 13047 Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000290105 Klebsiella aerogenes EA1509E Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241001214714 Niea Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000321111 Pseudomonas sp. HR 26 Species 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010054786 Skin burning sensation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- RHZUVFJBSILHOK-UHFFFAOYSA-N anthracen-1-ylmethanolate Chemical compound C1=CC=C2C=C3C(C[O-])=CC=CC3=CC2=C1 RHZUVFJBSILHOK-UHFFFAOYSA-N 0.000 description 1
- 239000003830 anthracite Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000002482 cold vapour atomic absorption spectrometry Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002013 dioxins Chemical class 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 101150111169 mer gene Proteins 0.000 description 1
- 101150109460 merB gene Proteins 0.000 description 1
- 101150002014 merT gene Proteins 0.000 description 1
- 102000022736 mercury ion binding proteins Human genes 0.000 description 1
- 108091013545 mercury ion binding proteins Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- YXVJNOXXPKIWIM-UHFFFAOYSA-N n-(2-hydroxyethyl)-n-(2-hydroxypropyl)nitrous amide Chemical compound CC(O)CN(N=O)CCO YXVJNOXXPKIWIM-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 239000002420 orchard Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 235000007183 paleface Nutrition 0.000 description 1
- 238000009304 pastoral farming Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 102220065742 rs200763765 Human genes 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 125000004436 sodium atom Chemical group 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Processing Of Solid Wastes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
一種汞污染生物整治用製劑及其使用方法,該汞污染生物整治用製劑包含:至少一種菌株,具有將離子汞還原成元素汞能力並能在3.5wt%海水鹽度下維持生長,該菌株選自陰溝腸桿菌(Enterobacter cloacae B37)、假單胞菌屬(Pseudomonas sp.A45)、假單胞菌屬(Pseudomonas sp.A46)或其任意組合,該些菌株不但可以高效率的將離子汞還原成毒性較低會揮發的元素汞由大氣加以稀釋,也適用於對鄰近海岸之汞污染廠址進行現地生物整治。由於該些菌株皆為本土菌株及未經基因改造,因此在現地使用上不會破壞或干擾本土之水體或含水土壤中的微生物菌相生態。 A mercury-contaminated biological remediation preparation comprising: at least one strain having the ability to reduce ionic mercury to elemental mercury and capable of maintaining growth at 3.5 wt% seawater salinity, the strain is selected from the group consisting of: from Enterobacter cloacae (Enterobacter cloacae B37), Pseudomonas (Pseudomonas sp.A45), Pseudomonas (Pseudomonas sp.A46) or any combination thereof, the plurality of strain can not only efficiently reducing the ionic mercury Elemental mercury, which is less toxic and volatile, is diluted by the atmosphere and is also suitable for in situ bioremediation of mercury-contaminated sites on adjacent coasts. Since these strains are all native strains and have not been genetically modified, they will not destroy or interfere with the microbial flora ecology in native water bodies or water-containing soils.
Description
本發明係關於一種汞污染生物整治用製劑及其使用方法,特別是關於一種可移除汞離子並具高耐鹽性之汞污染生物整治用製劑及其使用方法。 The present invention relates to a mercury-contaminated bioremediation preparation and a method of using the same, and more particularly to a mercury-contaminated bioremediation preparation capable of removing mercury ions and having high salt tolerance and a method of using the same.
汞(Hg)是一種天然存在的元素,在空氣,水和土壤中都可以發現它的存在。自然界的汞有以下幾種形式:元素(金屬態)汞,無機汞化合物和有機汞化合物。 Mercury (Hg) is a naturally occurring element found in air, water and soil. Mercury in nature has the following forms: elemental (metal) mercury, inorganic mercury compounds and organic mercury compounds.
在台灣常見的汞產品有電池、溫度計、血壓計、照明光源(如日光燈)、填補牙齒使用的汞齊、油漆、鏡面反射漆等,如果含汞的產品沒有適當的回收處理就會造成環境污染,而工業上主要的污染源則是鹼氯工廠。台灣早期鹼氯工廠生產燒鹼(氫氧化鈉)、氯氣、氫氣、鹽酸、漂白粉所使用的生產方法為水銀電解法,運作時以汞當陰極,石墨為陽極,去電解食鹽水。食鹽水中氯離子會在陽極被氧化成氯氣,而鈉離子在汞陰極被還原成鈉原子並溶解於汞中形成汞齊,汞齊再取出與另一水槽中的水反應產生氫氣與氫氧化鈉。此方法生產的氫氧化鈉的濃度高,純度好,在早期被大量使用,民國66年所進口的汞有80%被使用在鹼氯工廠的運作上。但此方法中當作陰極的汞常在沒有經過適當處理的情況下就與廢鹽水一同被排放,因而被這些廢水所污染的土壤就成為俗稱的「汞污泥」。由於後來環保意識的抬頭,在民國77年後已禁止使用水銀電解法來生產鹼氯。 Common mercury products in Taiwan include batteries, thermometers, sphygmomanometers, illumination sources (such as fluorescent lamps), amalgams used to fill teeth, paints, specular reflection paints, etc. If mercury-containing products are not properly recycled, they will cause environmental pollution. The main source of pollution in the industry is the alkali chlorine plant. The production method used in the early alkaline chlorine plant in Taiwan to produce caustic soda (sodium hydroxide), chlorine gas, hydrogen gas, hydrochloric acid and bleaching powder is mercury electrolysis. When operating, mercury is used as the cathode and graphite is used as the anode to dehydrate the brine. In the brine, chloride ions are oxidized to chlorine at the anode, and sodium ions are reduced to sodium atoms at the mercury cathode and dissolved in the mercury to form an amalgam. The amalgam is then taken out and reacted with water in another water tank to produce hydrogen and sodium hydroxide. . The sodium hydroxide produced by this method has a high concentration and good purity and was used in large quantities in the early stage. 80% of the mercury imported in the Republic of China in 66 years was used in the operation of the alkali chlorine plant. However, the mercury used as the cathode in this method is often discharged together with the waste brine without proper treatment, and the soil contaminated by these wastewaters is commonly known as "mercury sludge". Due to the rise of environmental awareness, the use of mercury electrolysis to produce alkali chloride was prohibited after 77 years of the Republic of China.
舉例來說,台南中石化安順廠舊場址,除了五氯酚和戴奧辛的污染之外,也存在汞污染,而該場址會有汞污染的主要原因即是其早先曾做為鹼氯工廠,而導致廠址附近的土地受到了汞的污染。這些汞的污染 如果不加以處理,不止對生態環境有很大的傷害,也會危及鄰近居民的身體健康。例如,無機汞化合物(如氯化汞)中之汞離子不僅會與氫硫基(sulfhydryl groups,R-SH)結合,也會與磷醯基(phosphoryl groups)、羧基(carboxyl groups,R-COOH)、醯胺基(amide groups)、胺基(amine groups)結合。當蛋白質中這些團基與汞反應結合,便會使蛋白質失去活性,而影響人體健康。暴露在含汞離子(氯化汞)環境下會引起以下症狀:(1)、刺激黏膜,並引起咳嗽、頭痛;(2)、引起皮膚灼熱感、皮膚炎或皮膚過敏;(3)、引起結膜或角膜之潰爛;(4)、引起口咽喉之灼熱感,且腹痛、嘔吐或下痢;及(5)、脈搏跳動微弱、臉色蒼白呼吸衰甚至引起腎竭而導致死亡等。因此,有必要對遭受汞污染的土壤進行整治處理。 For example, in addition to the pollution of pentachlorophenol and dioxins, the old site of Tainan Sinopec Anshun Plant also has mercury pollution, and the main reason for mercury pollution at this site is that it was previously used as an alkali chlorine plant. As a result, the land near the site was contaminated with mercury. Pollution of these mercury If left untreated, it will not only cause great harm to the ecological environment, but also endanger the health of neighboring residents. For example, mercury ions in inorganic mercury compounds (such as mercury chloride) not only bind to sulfhydryl groups (R-SH), but also to phospholy groups, carboxyl groups (R-COOH). ), amide groups, amine groups. When these groups in the protein react with mercury, the protein is inactivated and affects human health. Exposure to mercury-containing ions (mercury chloride) can cause the following symptoms: (1) irritating the mucous membrane and causing cough and headache; (2) causing skin burning sensation, dermatitis or skin irritation; (3) causing (7), causing a burning sensation in the oropharynx, and abdominal pain, vomiting or diarrhea; and (5), weak pulse beat, pale face respiratory failure or even cause kidney exhaustion and death. Therefore, it is necessary to remediate the soil contaminated with mercury.
常見的汞污染處理方式列舉說明如下: The common mercury pollution treatment methods are listed as follows:
(1)、固定法:藉由添加硫化物(如硫化鈉,sodium sulfide,Na2S)還原土壤中的汞污染物,以形成硫化汞沉澱,是一種穩定汞污染土壤和物質的方法。硫化汞相對上溶解度較低,亦比其他形式的汞不易揮發,可以減少汞的危害。另外,在有汞污染的水溶液中加入硫化鈉也可以有效的固定汞離子,並經過過濾去除水中的汞污染物。 (1), fixation method: by adding sulfide (such as sodium sulfide, sodium sulfide, Na 2 S) to reduce mercury pollutants in the soil to form mercury sulfide precipitation, is a method to stabilize mercury contaminated soil and matter. Mercury sulphide has a relatively low solubility and is less volatile than other forms of mercury, which can reduce the risk of mercury. In addition, the addition of sodium sulfide to an aqueous solution contaminated with mercury can also effectively immobilize mercury ions and remove mercury contaminants from the water by filtration.
(2)、熱處理法:熱處理法利用加熱來使汞污染物揮發並與固體基質(土壤、污泥)分離,之後這些分離出來的污染物再經由廢氣處理系統去控制廢氣排放。例如,使用熱處理法處理瑞典一處鹼氯廠汞污染土壤,將汞污染土壤在460℃下熱處理20分鐘,汞的去除效率可達99%;亦有採用熱處理法以600℃去處理汞污染土壤,結果顯示90%的土壤中的汞污染可以成功地被去除,且汞和廢氣中的有機物質可以被收集起來。 (2) Heat treatment method: The heat treatment method uses heating to volatilize the mercury pollutants and separate them from the solid matrix (soil, sludge), and then the separated pollutants are controlled by the exhaust gas treatment system to discharge the exhaust gas. For example, a heat treatment method is used to treat mercury-contaminated soil in an alkaline chlorine plant in Sweden, and the mercury-contaminated soil is heat-treated at 460 ° C for 20 minutes, and the mercury removal efficiency can reach 99%. There is also a heat treatment method to treat mercury-contaminated soil at 600 ° C. The results show that 90% of the mercury contamination in the soil can be successfully removed, and the organic matter in the mercury and exhaust gases can be collected.
(3)、微生物處理法:細菌中和汞耐受性有關的基因統稱為mer基因群,這些基因共同組成汞操作子(mercury operons),其可以調控細菌對於汞化合物的代謝,因此含有汞操作子的細菌是有處理汞污染物的潛力的。汞操作子上的基因分別有merA、merB、merP、merT、merE、merG、merR和merD等等,它們所表現的蛋白質分別為MerA、MerB、MerP、MerT、MerE、MerG、MerR和MerD,各具有代謝汞的特定功能。例如,利用細菌中被merA基因所調控的汞還原酶(Mercuric reductase,MerA),可以將離子
汞(Hg2+)還原成毒性較低會揮發的元素汞(Hg)至大氣中或可加以回收揮發汞。另外,有機汞裂解酶(organomercurial lyase,MerB),則是可以催化碳汞鍵的分解,將有機汞分解成毒性較低的離子汞(Hg2+),MerA與MerB作用機制如下:
已知之微生物處理法之相關研究及應用列舉說明如下:美國專利第3,923,597號揭示一種用以明顯減少汞污染水液的汞含量之處理方法,藉由將MER質體以基因工程方式植入一菌株(Pseudomonas putida)中得到可用於處理汞污染的生物整治菌株。 A related study and application of the known microbial treatment method is described as follows: U.S. Patent No. 3,923,597 discloses a treatment method for significantly reducing the mercury content of mercury-contaminated aqueous liquid by genetically engineering a MER plastid into a strain. ( Pseudomonas putida ) provides bioremediation strains that can be used to treat mercury contamination.
國立中山大學王湘斐於1997年所作「抗汞菌生理及抗汞基因之研究」論文中,針對二仁溪及三爺宮溪流域,以pHG106的mer operon當作探針篩選耐汞菌株,選定十六株進行抗汞基因相似度測試,同時也將pHG106的merP基因選殖到質體pKK223-3上,且置回大腸桿菌E.coli JM109中,以做為基因改造之汞污染生物整治菌株。 Wang Xiangfei, National Sun Yat-Sen University, in the paper "Study on the Physiology of Mercury-Resistant Bacteria and Anti-Hybrid Genes" in 1997, screened for mercury-resistant strains using mer operon of pHG106 as a probe for the Errenxi and Sanyegong River basins. Six strains were tested for anti-mercury gene similarity, and the merP gene of pHG106 was also cloned into plastid pKK223-3 and returned to E. coli JM109 as a genetically modified mercury-contaminated bioremediation strain.
國立中興大學謝儒樑於2002年所作「應用汞離子結合蛋白MerP於重金屬生物修復上之研究」論文中,利用具汞抗性的革蘭氏陽性菌Bacillus cereus RC607,以及陰性菌Pseudomonas aerugenosa K-62汞抗性基因組中的汞離子結合蛋白MerP,分別在大腸菌E.coli BL21(DE3)pLysS中表現,以做為基因改造之汞污染生物整治菌株。 Xie Junliang of National Chung Hsing University in 2002, "The application of mercury ion binding protein MerP to the bioremediation of heavy metals", the use of mercury-resistant Gram-positive bacteria Bacillus cereus RC607, and the negative bacteria Pseudomonas aerugenosa K-62 mercury The Mercury-binding protein MerP in the resistance genome was expressed in Escherichia coli BL21(DE3)pLysS, respectively, as a genetically modified mercury-contaminated bioremediation strain.
逢甲大學羅文鑫於1997年所作「以抗汞微生物發展汞廢水生物去毒程序之研究」論文中,由醫療廢水中篩選出具抗汞質體(Rip64)之綠膿桿菌(Pseudomonas aerugoinsa PU21)做為抗汞菌種,用於進行汞廢水去毒處理。 In the paper “Research on the Biological Detoxification Process of Mercury Wastewater by Mercury-Resistant Microorganisms” by Feng Wenxin of Fengjia University in 1997, Pseudomonas aerugoinsa PU21 with anti-mercury plastids (Rip64) was selected from medical wastewater. Anti-mercury bacteria used for detoxification of mercury wastewater.
然而,上述研究及應用仍具有下述問題:美國專利第3,923,597號之菌株來源並非台灣本土菌株,且需涉及複雜基改工程,因此若欲輸入使用於台灣本土,必需耗時評估是否影響本土之土壤微生物相生態。王湘斐、謝儒樑以大腸桿菌做為基因改造之汞污染生物整治菌株同樣 涉及複雜基改工程且需耗時評估是否破壞或干擾本土之土壤微生物菌相生態。羅文鑫由醫療廢水中篩選出之抗汞菌種較適用於廢水去毒處理,對於土壤環境之處理綜效仍待評估。值得注意的是,上述提及之菌株皆未針對海水鹽度之耐受性進行評估,且眾所周知,即使是同種不同品系(strain)之細胞株,在生理特性及功能仍存在有相當大的差異。因此,對於鄰近海岸鹽度較高之汞污染場址而言,該些基改菌株或篩選菌株或許具有較高之有機汞降解能力或離子汞還原能力,但當其使用在鄰近海岸之汞污染場址後卻可能因不適應富含水份之環境以及對海水鹽度之耐受性差,而無法持續存活及繁殖,因而降低應用在近海土壤進行汞污染生物整治之實際成效。 However, the above research and application still have the following problems: The source of the strain of U.S. Patent No. 3,923,597 is not a native strain of Taiwan, and involves a complicated base reform project. Therefore, if it is to be used in Taiwan, it is necessary to evaluate whether it affects the local. Soil microbial phase ecology. Wang Xiangfei and Xie Ruliang use Escherichia coli as a genetically modified mercury-contaminated bioremediation strain. It involves complex base-change projects and requires time-consuming assessment to destroy or interfere with the soil microbial flora ecology of the native soil. Luo Wenxin's anti-mercury strains selected from medical wastewater are more suitable for wastewater detoxification treatment, and the comprehensive effect on soil environment treatment remains to be evaluated. It is worth noting that none of the above mentioned strains have been evaluated for tolerance to seawater salinity, and it is well known that even cell lines of the same strain have considerable differences in physiological characteristics and functions. . Therefore, for mercury-contaminated sites with high salinity near the coast, these strains or screening strains may have higher organic mercury degradation capacity or ionic mercury reduction capacity, but when used in mercury pollution near the coast After the site, it may not be able to adapt to the water-rich environment and the tolerance to seawater salinity, and it is unable to sustain survival and reproduction, thus reducing the practical effect of applying mercury pollution bioremediation in offshore soil.
故,有必要提供一種汞污染生物整治用製劑及其使用方法,以解決習用技術所存在的問題。 Therefore, it is necessary to provide a mercury-contaminated bioremediation preparation and a method for using the same to solve the problems of the conventional technology.
本發明之主要目的在於提供一種汞污染生物整治用製劑及其使用方法,其係由台灣本土鄰近海岸之汞污染廠址現地篩選出特定菌株,其具有較高之汞還原酶(MerA)表現量且同時具備較高之海水鹽度耐受性,因此不但可以高效率的將離子汞(Hg2+)還原成毒性較低會揮發的元素汞(Hg)由大氣加以稀釋,也可以適用於對鄰近海岸之汞污染廠址進行現地生物整治。同時,該菌株之篩選、培養迅速,製劑成本低廉,移除汞離子所需時間短,及移除成效顯著。 The main object of the present invention is to provide a mercury-contaminated bioremediation preparation and a method for using the same, which are to screen a specific strain from a mercury-contaminated site near the coast of Taiwan, which has a high mercury reductase (MerA) expression amount and At the same time, it has high seawater salinity tolerance, so it can not only reduce the ionic mercury (Hg 2+ ) to a less toxic elemental mercury (Hg), which is diluted by the atmosphere, but also can be applied to the adjacent On-site bioremediation of mercury-contaminated sites on the coast. At the same time, the strain is screened and cultured rapidly, the preparation cost is low, the time required to remove mercury ions is short, and the removal effect is remarkable.
本發明之次要目的在於提供一種汞污染生物整治用製劑及其使用方法,其係由台灣本土鄰近海岸之汞污染廠址現地篩選出特定菌株,該些特定菌株皆為本土菌株及未經基因改造,因此在現地使用上不存在破壞或干擾本土之水體或含水土壤中微生物菌相生態之疑慮,且該菌株也可在整治現場繼續繁殖,持續移除汞離子污染物。 A secondary object of the present invention is to provide a mercury-contaminated bioremediation preparation and a method for using the same, which are selected from a local mercury-contaminated site on the local coastal area of Taiwan, which are native strains and have not been genetically modified. Therefore, there is no doubt about the destruction or interference of the microbial flora in the local water body or the watery soil in the field, and the strain can continue to reproduce at the remediation site, and the mercury ion contaminants are continuously removed.
本發明之另一目的在於提供一種汞污染生物整治用製劑及其使用方法,其係由台灣本土鄰近海岸之汞污染廠址現地篩選出三種特定菌株,並同時複合使用於汞污染廠址現地進行整治,複合使用多種菌株有利於確保能有某一種菌株能存活及適應該現地環境,並可在整治現場繼續繁殖,持續移除汞離子污染物,以相對提高整治成效及降低整治次數。 Another object of the present invention is to provide a mercury-contaminated bioremediation preparation and a method for using the same, which are to screen three specific strains locally from a mercury-contaminated site near the coast of Taiwan, and simultaneously use it in a mercury-polluted site for remediation. The combined use of multiple strains is beneficial to ensure that a certain strain can survive and adapt to the local environment, and can continue to reproduce at the remediation site, and continuously remove mercury ion contaminants to relatively improve the remediation effect and reduce the number of remediation.
為達上述之目的,本發明提供一種汞污染生物整治用製劑,其包含:至少一種菌株,具有將離子汞還原成元素汞能力並能在3.5wt%海水鹽度下維持生長,該菌株選自陰溝腸桿菌(Enterobacter cloacae B37)、假單胞菌屬(Pseudomonas sp.A45)、假單胞菌屬(Pseudomonas sp.A46)或其任意組合,該些菌株依序以寄存編號BCRC 910603、BCRC 910604及BCRC 910605寄存於食品工業發展研究所的生物資源保存及研究中心(BCRC of FIRDI)。 To achieve the above object, the present invention provides a mercury-contaminated bioremediation preparation comprising: at least one strain having the ability to reduce ionic mercury to elemental mercury and capable of maintaining growth at 3.5 wt% seawater salinity, the strain being selected from the group consisting of Enterobacter cloacae (Enterobacter cloacae B37), Pseudomonas (Pseudomonas sp.A45), Pseudomonas (Pseudomonas sp.A46) or any combination thereof, the plurality of sequentially to strain Accession No. BCRC 910603, BCRC 910604 And BCRC 910605 is hosted by the Center for Bioresource Conservation and Research (BCRC of FIRDI) at the Food Industry Development Institute.
在本發明之一實施例中,該菌株係篩選自台南中石化安順廠舊場址之土壤。 In one embodiment of the invention, the strain is screened from the soil of the old site of the Anshun Plant of Tainan Sinopec.
在本發明之一實施例中,該汞污染生物整治用製劑同時包含陰溝腸桿菌(Enterobacter cloacae B37)、假單胞菌屬(Pseudomonas sp.A45)及假單胞菌屬(Pseudomonas sp.A46)三種菌株。 In one embodiment of the present invention, the mercury bioremediation formulations containing Enterobacter cloacae (Enterobacter cloacae B37) at the same time, the genus Pseudomonas (Pseudomonas sp.A45) and Pseudomonas (Pseudomonas sp.A46) Three strains.
在本發明之一實施例中,該陰溝腸桿菌B37、假單胞菌屬A45及假單胞菌屬A46之混合比例為1至10:1至10:1至10。 In one embodiment of the present invention, the mixing ratio of the Enterobacter cloacae B37, Pseudomonas A45, and Pseudomonas A46 is from 1 to 10:1 to 10:1 to 10.
在本發明之一實施例中,該混合比例為1:1:1。 In an embodiment of the invention, the mixing ratio is 1:1:1.
在本發明之一實施例中,該菌株係包埋於一生物可相容的載體(biocompatible carrier)中;或披覆於一生物可相容的載體顆粒上。 In one embodiment of the invention, the strain is embedded in a biocompatible carrier; or coated on a biocompatible carrier particle.
另外,本發明提供一種汞污染生物整治用製劑之使用方法,其包含步驟:提供一種如上所述之汞污染生物整治用製劑;以及將該汞污染生物整治用製劑施加於台灣地區之一汞污染廠址,以進行現地生物整治。 In addition, the present invention provides a method for using a mercury-contaminated bioremediation preparation comprising the steps of: providing a mercury-contaminated biological remediation preparation as described above; and applying the mercury-contaminated bioremediation preparation to a mercury contamination in Taiwan The site is for local bioremediation.
在本發明之一實施例中,將該汞污染生物整治用製劑係對於該汞污染廠址現地之地下水、廢水,或是含水之土壤、污泥或沉積物進行生物整治。 In one embodiment of the present invention, the mercury-contaminated bioremediation preparation is used for bioremediation of groundwater, wastewater, or aqueous soil, sludge or sediment in the mercury contaminated site.
在本發明之一實施例中,該台灣本土之汞污染廠址係一鄰近海岸之汞污染廠址。 In one embodiment of the invention, the local mercury contaminated site in Taiwan is a mercury contaminated site adjacent to the coast.
在本發明之一實施例中,該鄰近海岸之汞污染廠址係為台南中石化安順廠舊場址。 In an embodiment of the invention, the mercury contaminated site adjacent to the coast is the old site of the Anshun Plant of Tainan Sinopec.
第1A及1B圖:本發明測試菌株B37之耐鹽性的生長曲線圖。 Figures 1A and 1B: Growth curve of salt tolerance of test strain B37 of the present invention.
第2A及2B圖:本發明測試菌株A45之耐鹽性的生長曲線圖。 Figures 2A and 2B: Growth curves of the salt tolerance of the test strain A45 of the present invention.
第3A及3B圖:本發明測試菌株A46之耐鹽性的生長曲線圖。 Figures 3A and 3B: Growth curves of the salt tolerance of the test strain A46 of the present invention.
第4A及4B圖:本發明測試菌株B37之耐受汞離子能力的生長曲線圖。 Figures 4A and 4B: Growth curves of the ability of the test strain B37 to withstand mercury ion tolerance of the present invention.
第5A及5B圖:本發明測試菌株A45之耐受汞離子能力的生長曲線圖。 Figures 5A and 5B: Growth curves of the ability of the test strain A45 to withstand mercury ion tolerance of the present invention.
第6A及6B圖:本發明測試菌株A46之耐受汞離子能力的生長曲線圖。 Figures 6A and 6B: Growth curve of the ability of the test strain A46 to withstand mercury ion in the present invention.
第7A、7B及7C圖:本發明測試六種菌株組分別在含汞離子60ppm的NB、PMM、LB三種培養基中之汞離子移除能力的曲線圖。 Figures 7A, 7B, and 7C: The present invention tests a graph of mercury ion removal ability of the six strain groups in three mediums of NB, PMM, and LB containing mercury ions of 60 ppm.
為了讓本發明之上述及其他目的、特徵、優點能更明顯易懂,下文將特舉本發明較佳實施例,並配合所附圖式,作詳細說明如下。再者,本發明所提到的方向用語,例如上、下、頂、底、前、後、左、右、內、外、側面、周圍、中央、水平、橫向、垂直、縱向、軸向、徑向、最上層或最下層等,僅是參考附加圖式的方向。因此,使用的方向用語是用以說明及理解本發明,而非用以限制本發明。 The above and other objects, features and advantages of the present invention will become more <RTIgt; Furthermore, the directional terms mentioned in the present invention, such as upper, lower, top, bottom, front, rear, left, right, inner, outer, side, surrounding, central, horizontal, horizontal, vertical, longitudinal, axial, Radial, uppermost or lowermost, etc., only refer to the direction of the additional schema. Therefore, the directional terminology used is for the purpose of illustration and understanding of the invention.
本發明係用以提供一種汞污染生物整治用製劑及其使用方法,其主要係由一台灣本土受汞離子污染之場址中篩選分離出可於短天期將大量的離子汞(Hg2+)還原成毒性較低會揮發的元素汞(Hg)且具備較高之海水鹽度耐受性的台灣本土菌株,以應用於台灣本土各種受汞污染環境之水體或含水土壤的生物整治復育,因此上述菌株確實可在不影響本土微生物菌相生態系統下適用於台灣本土環境,並可獲得快速及有效之微生物整治處理成效。本發明以下述方法篩選出三株本土菌株,均含有merA基因(gene),可以表現出汞還原酶,將汞離子(Hg2+)還原成元素汞(Hg),並揮發至大氣中稀釋,故皆可以有效處理受汞離子污染的水體及含水土壤;同時該些本土菌株也皆能在3.5wt%海水鹽度下維持生長。本發明將於下文利用實驗例及圖示逐一詳細說明本發明篩選菌種及確認菌種能力的詳細實驗過 程及分析方法。 The invention is used for providing a mercury-contaminated biological remediation preparation and a method for using the same, which is mainly selected from a site contaminated by mercury ions in Taiwan, and can extract a large amount of ionic mercury (Hg 2+ ) in a short period of time. Reducing to native Taiwanese strains with low toxicity and volatile elemental mercury (Hg) and high seawater salinity tolerance for bioremediation and remediation in various water bodies or water-containing soils in Taiwan Therefore, the above strains can be applied to the local environment of Taiwan without affecting the indigenous microbial ecosystem, and the rapid and effective microbial remediation treatment effect can be obtained. The present invention screens three native strains, which all contain the merA gene, can exhibit mercury reductase, reduce mercury ions (Hg 2+ ) to elemental mercury (Hg), and volatilize to the atmosphere to dilute, Therefore, water bodies and water-containing soils contaminated by mercury ions can be effectively treated; and these native strains can also maintain growth under 3.5% by sea seawater salinity. The present invention will be described in detail below using the experimental examples and the illustrations to explain in detail the detailed experimental procedure and analytical method for screening the strains and confirming the strains of the present invention.
實驗材料與方法: Experimental materials and methods:
(一)菌株的篩選方法 (1) Screening method of strains
土壤樣品來自台灣南部汞污染場址(台南中石化安順廠舊場址)之土壤。菌株的篩選方法為取3g的土壤至15ml的離心管中,並加入8ml的NB培養液(nutrient broth)中,於30℃、轉速100rpm的震盪培養箱中培養16hr。將培養好的菌液繼代培養於8ml含20ppm氯化汞(HgCl2)的培養液中16hr,之後再以相同方式繼代培養並逐步提高氯化汞(HgCl2)的濃度到40ppm及60ppm。將含60ppm氯化汞的菌液取出100μl加入900μl的培養液作序列稀釋10-1~10-8。每種稀釋倍率的菌液取100μl分別塗在含有100ppm氯化汞濃度的NA洋菜膠培養基(nutrient agar)上,培養於30℃的培養箱中16hr。16hr後選取能區分出單一菌落(colony)的培養皿,隨機挑選95個單一菌落,並編號,以便之後做merA基因的檢測。 The soil samples were obtained from the soil of the mercury-contaminated site in southern Taiwan (the old site of Tainan Sinopec Anshun Plant). The screening method of the strain was to take 3 g of the soil into a 15 ml centrifuge tube, and add 8 ml of NB culture solution (nutrient broth), and incubate in a shaking incubator at 30 ° C and a rotation speed of 100 rpm for 16 hr. The cultured bacterial solution was subcultured in 8 ml of a culture solution containing 20 ppm of mercuric chloride (HgCl 2 ) for 16 hr, and then subcultured in the same manner and gradually increased the concentration of mercury chloride (HgCl 2 ) to 40 ppm and 60 ppm. . 100 μl of the bacterial solution containing 60 ppm of mercuric chloride was added to 900 μl of the culture solution for serial dilution of 10 -1 to 10 -8 . 100 μl of each dilution ratio of the bacterial solution was applied to a nutrient agar containing 100 ppm of mercury chloride, and cultured in an incubator at 30 ° C for 16 hr. After 16 hr, a petri dish capable of distinguishing a single colony (colony) was selected, and 95 single colonies were randomly selected and numbered for subsequent detection of the merA gene.
以含60ppm氯化汞(HgCl2)培養液培養並挑選出單一菌落後,所篩選到的菌株總共有95株,初步編號為A1~48及B1~47,由此可以初步確定所篩選出的菌株至少能耐受60ppm氯化汞(HgCl2)。 After culturing with 60ppm mercury chloride (HgCl 2 ) medium and selecting a single bacteria, the total number of strains screened was 95, the initial numbers were A1~48 and B1~47, which can be used to determine the selected ones. The strain is resistant to at least 60 ppm of mercuric chloride (HgCl 2 ).
(二)菌株DNA的萃取 (2) Extraction of strain DNA
將菌株培養在含60ppm氯化汞的培養液中直到吸光值(OD 600nm)>0.3。取1.5ml的菌液離心去除培養基,以100μl TE緩衝液(1mM EDTA,10mM Tris,pH 8.0)重新懸浮細胞,並加入溶菌酵素(lysozyme)100mg/ml,震盪均勻後放入37℃的水浴槽中培養30min,每15min震盪一次。30min水浴後加入350μl TE緩衝液、30μl 10% SDS、5μl蛋白酶K(proteinase K)20mg/ml,震盪均勻後放入56℃水浴槽中培養1hr。1hr結束後加入100μl 5M NaCl溶液混合均勻,再加入等體積的冰苯酚(phenol)約650μl,並在離心後取上清液到新的離心管中,加入等體積(約600μl)的冰氯仿/IAA(24:1),混合均勻後離心,並取上清液到新的離心管中,加入兩倍體積的(約1000μl)的冰異丙醇後靜置12hour。之後,再離心及去除上清液,以70%乙醇沖洗沉澱物後,離心去除上清液並以冷凍乾燥機將沉澱物乾燥後以去離子水(ddH2O)回溶。回溶後可進行瓊脂膠體電泳(agarose gel electrophoresis),膠體濃度為0.8%,電泳結束後膠體以EtBr(ethidium bromide)染色,再使用UV燈激發照相確認產物。 The strain was cultured in a culture solution containing 60 ppm of mercuric chloride until the absorbance (OD 600 nm) was >0.3. 1.5 ml of the bacterial solution was centrifuged to remove the medium, and the cells were resuspended in 100 μl of TE buffer (1 mM EDTA, 10 mM Tris, pH 8.0), and lysozyme (100 mg/ml) was added thereto. After shaking, the cells were placed in a 37 ° C water bath. The medium was incubated for 30 min and oscillated every 15 min. After 30 min of water bath, 350 μl of TE buffer, 30 μl of 10% SDS, and 5 μl of proteinase K (20 mg/ml) were added, shaken evenly, and placed in a 56 ° C water bath for 1 hr. After 1 hr, add 100 μl of 5 M NaCl solution to mix well, then add an equal volume of phenol 650 μl, and after centrifugation, take the supernatant into a new centrifuge tube and add an equal volume (about 600 μl) of ice chloroform / IAA (24:1), mix well, centrifuge, and take the supernatant into a new centrifuge tube, add two volumes (about 1000 μl) of ice isopropanol and let stand for 12 hours. Thereafter, the supernatant was again centrifuged and removed, and the precipitate was washed with 70% ethanol, and the supernatant was removed by centrifugation and the precipitate was dried in a freeze dryer and then dissolved in deionized water (ddH 2 O). After re-dissolving, agarose gel electrophoresis can be performed, and the colloid concentration is 0.8%. After the electrophoresis, the colloid is stained with EtBr (ethidium bromide), and the product is confirmed by UV lamp excitation.
(三)檢測有無merA基因 (3) Detecting the presence or absence of the merA gene
以PCR檢測merA基因所使用的引子(primers)為正向(forward)A1s-n.F與反向(reverse)A5-n.R,其序列係列於下表1(Chadhain et al.,2006,Environ.Microbiol.8:1746-1752)。以上述引子進行已知PCR程序後,PCR產物使用1.5%的瓊脂膠體,進行電泳(agarose gel electrophoresis),電泳結束以EtBr染色後使用UV燈激發照相,分析PCR product的大小,以檢測merA基因的有無。 In primer (primers) PCR detection of gene merA used forward (forward) A1s-nF reverse (reverse) A5-nR, in which series the sequence in Table 1 (Chadhain et al., 2006 , Environ.Microbiol. 8:1746-1752). After the above procedures known PCR primer, PCR product was purified using 1.5% agar gel, electrophoresis (agarose gel electrophoresis), stained with EtBr after electrophoresis ending with excitation light using a UV camera, the size of the PCR Product analysis to detect gene merA There is no.
由汞污染場址篩選獲得的95株菌株中若帶有merA基因,就會有能力將離子汞(Hg2+)還原成元素汞(Hg),並有潛力應用於整治汞污染場址。因此,先以引子A1s-n.F與A5-n.R進行PCR,以檢測菌株是否帶有merA基因。帶有merA gene的菌株其含有的merA基因序列可以經由PCR擴增,擴增的片段大小約為285bps左右,由1.5%的瓊脂膠體電泳後照膠所得的結果可知,具有285bps的菌株可以初步判定是含有merA gene的菌株,初步篩出可能帶有merA gene的菌株共有40株,編號分別為A39、A41、A45、A46、B1~7、B9~24、B26、B27、B35、B37~46。 The 95 strains screened by mercury-contaminated sites, with the merA gene, have the ability to reduce ionic mercury (Hg 2+ ) to elemental mercury (Hg) and have potential for remediation of mercury-contaminated sites. Therefore, PCR was first performed with the primers A1s-nF and A5-nR to detect whether the strain carries the merA gene. MerA strain which contained the gene sequence with the merA Gene amplification via PCR, the amplified fragment size is about 285bps, as apparent from the results obtained in the 1.5% agar gel electrophoresis colloid, a strain having a preliminary determination may 285bps It is a strain containing merA gene. A total of 40 strains with merA gene may be screened, numbered A39, A41, A45, A46, B1~7, B9~24, B26, B27, B35, B37~46.
(四)變性梯度凝膠電泳(denaturing gradient gel electrophoresis,DGGE)篩選去除重複菌種 (4) Denaturing gradient gel electrophoresis (DGGE) screening to remove repetitive strains
由於起初是隨機挑選菌種的,所以挑選出的菌株會有一部份為相同重複的菌種,因此檢測完merA基因後,需使用變性梯度凝膠電泳(denaturing gradient gel electrophoresis,DGGE)分析法來取得16S rDNA片段以進一步分析判斷彼此是否為相同的菌種,其中相同菌種的多個菌株皆只挑選其中一菌株為代表進行後續特性分析。DGGE分析法的操作步驟已見
於文獻(Nübel et al.,1996,J.Bacteriol.178:5636-5643),故於此不再予詳細說明,及其使用的16S rDNA片段PCR引子如下:
在上述步驟(三)初步篩選出帶有merA gene的菌株數量為40株之後,本發明隨即使用DGGE分析法取得各菌株16S rDNA電泳亮帶位置,藉此比對刪除相同重複的菌株,結果顯示編號B1~2、B4~7、B9~20、B22~25、B27、B35、B37~46可能為相同的菌種,它們的16S rDNA的V6~V8變異區(high variable region)片段在DGGE電泳膠片中所形成的亮帶(bands)都在相同水平位置上,因此分別只挑選其中一菌株為代表做接下來的merA基因序列及16S rDNA序列的定序。經DGGE刪除後,確定為不同菌株的編號分別為B37、A39、A41、A45、A46共五株。雖然其中A39、A41、A45、A46的菌株16S rDNA亮帶在的位置很相近,但是仍有些微的差距,所以初步先判定為不同的菌種。 After the preliminary screening of the number of strains carrying the merA gene was 40 in the above step (3), the present invention immediately used the DGGE analysis method to obtain the position of the 16S rDNA electrophoresis bright band of each strain, thereby deleting the same repeated strains, and the results showed Nos. B1~2, B4~7, B9~20, B22~25, B27, B35, B37~46 may be the same species, and their 16S rDNA V6~V8 variant region (high variable region) fragment in DGGE The bands formed in the film are all at the same horizontal position, so only one of the strains is selected to represent the sequence of the next merA gene sequence and the 16S rDNA sequence. After deletion by DGGE, the number of different strains was determined to be five strains of B37, A39, A41, A45 and A46. Although the 16S rDNA bright bands of the strains A39, A41, A45 and A46 are in similar positions, there are still some slight differences, so it is initially determined to be different strains.
(五)菌株merA基因的定序及比對 (5) Sequencing and alignment of strain merA gene
針對B37、A39、A41、A45、A46,將這五株在步驟(三)由PCR放大出的merA基因序列進一步先藉由插入載體(如pGEM®-T Easy Vector)中及植入菌株(如ECOSTM 101 competent cells)中的方式,來培養得到克隆庫(clone library)。之後,再委託基龍米克斯(Genomics)定序公司定序插入載體上的merA基因片段,完成後得到的merA基因序列如下(SEQ ID NO:5~9)。 For the B37, A39, A41, A45, A46, the five merA gene sequences amplified by PCR in step (3) are further inserted into the vector (such as pGEM ® -T Easy Vector) and the implanted strain (such as The method in ECOS TM 101 competent cells) was used to culture a clone library. Thereafter, the group entrust Long Meeks (Genomics) sequencing sequencing company merA gene fragment inserted in the vector, merA gene sequences was performed to obtain the following (SEQ ID NO: 5 ~ 9 ).
接著,上述五菌株的merA基因序列(SEQ ID NO:5~9)再經由NCBI網頁的nucleotide BLAST之Others(nr etc.):Nucleotide collection(nr/nt)資料庫中與已發表的merA基因序列作比對,由比對後的結果得知,其中編號B37的merA基因和Enterobacter aerogenes EA1509E的質體pEA1509_A的merA基因為最相似,相似度為97%,而A39、A41、A45、 A46則與Pseudomonas putida SP1的相似度是比較高的,相似度分別為99%、99%、99%、91%。將它們的序列再經過clustalw tool軟體作多重序列比對(multiple alignment),發現雖然A39、A41、A45、A46都與Pseudomonas putida SP1為最相似,但它們基因序列之間仍有些許的不同,其中A39、A41、A45彼此之間是較相近的,而與B37、A46的merA基因序列則是較不相近的。 Next, the merA gene sequences of the above five strains (SEQ ID NOS: 5-9) were further sequenced with the published merA gene sequence from the nucleotides BLAST's Others (nr etc.):Nucleotide collection (nr/nt) database on the NCBI webpage. for comparison, the result of that ratio, wherein merA merA gene and the gene of the Enterobacter aerogenes EA1509E number plastid pEA1509_A B37 is most similar, 97% similarity, and A39, A41, A45, A46 and the Pseudomonas The similarity of putida SP1 is relatively high, and the similarities are 99%, 99%, 99%, and 91%, respectively. Their sequences were further subjected to multiple alignment by the clustalw tool software. It was found that although A39, A41, A45 and A46 were most similar to Pseudomonas putida SP1, there were still some differences between their gene sequences. A39, A41, and A45 are relatively similar to each other, but the merA gene sequences of B37 and A46 are less similar.
B37-merA基因之序列(SEQ ID NO:5)如下: The sequence of the B37- merA gene (SEQ ID NO: 5) is as follows:
A39-merA基因之序列(SEQ ID NO:6)如下: The sequence of the A39- merA gene (SEQ ID NO: 6) is as follows:
A41-merA基因之序列(SEQ ID NO:7)如下: CGGA-3’ The sequence of the A41- merA gene (SEQ ID NO: 7) is as follows: CGGA-3'
A45-merA基因之序列(SEQ ID NO:8)如下: The sequence of the A45- merA gene (SEQ ID NO: 8) is as follows:
A46-merA基因之序列(SEQ ID NO:9)如下: The sequence of the A46- merA gene (SEQ ID NO: 9) is as follows:
(六)菌種的屬名、種名鑑定 (6) Identification of the genus name and species name of the strain
針對B37、A39、A41、A45、A46,將這五種菌株進一步先以細菌通用引子(bacterial universal primers)9f與1525r(Bano and Hollibaugh,2002,Appl.Environ.Microbiol.68:505-518.)進行PCR以擴增特定的16S rDNA片段,接著再以上述藉由插入載體(如pGEM®-T Easy Vector)中及植入菌株(如ECOSTM 101 competent cells)中的相同方式製作另一克隆庫(clone library),隨後再以另二引子T7、SP6(Tennant et al.,2005,Infect.Immun.73:6860-6867)進行PCR再次擴增一較長的16S rDNA片段,其帶有足供鑑別菌株種類的基因序列。 For the B37, A39, A41, A45, and A46, these five strains were further preceded by bacterial universal primers 9f and 1525r (Bano and Hollibaugh, 2002, Appl. Environ. Microbiol. 68:505-518.) Perform PCR to amplify a specific 16S rDNA fragment, and then make another clone library in the same manner as described above by inserting the vector (eg pGEM ® -T Easy Vector) and implanting the strain (eg ECOS TM 101 competent cells) (clone library), followed by another two primers T7, SP6 (Tennant et al., 2005, Infect. Immun. 73: 6860-6867) for PCR amplification of a longer 16S rDNA fragment with sufficient supply Identify the gene sequence of the strain species.
接著,委託基龍米克斯(Genomics)定序公司定序此較長的16S rDNA片段,完成後得到的16S rDNA基因序列如下(SEQ ID NO:14~18);隨後,由NCBI網站比對後的結果可知,編號B37、A39、A41、A45、A46菌株的16S rDNA序列分別與Enterobacter cloacae subsp.cloacae ATCC 13047、Pseudomonas sp.BF-2、Pseudomonas sp.HR 26、Pseudomonas sp.BF-2、Pseudomonas sp.HR 26的16S rDNA序列相似度分別為99%、99%、100%、99%、99%。由過去文獻指出序列相似度97%以上即可判定菌株為相同菌種(Gevers et al.,2005),因此B37菌株其菌種為Enterobacter cloacae(陰溝腸桿菌),而A39、A45、A41與A46皆為Pseudomonas sp.(假單胞菌屬)。將此五菌株的16S rDNA序列經由clustalw tool軟體作多重序列比對後也顯示A39與A45之間是較相近的;A41與A46菌株之間是較為相近的;而B37菌株與其他四菌株的親緣關係是較遠的。因此,下述將以B37、A45與A46三菌株為代表進行菌株特性測試。 Next, the Genomics sequencing company was commissioned to sequence the longer 16S rDNA fragment, and the 16S rDNA gene sequence obtained was as follows (SEQ ID NOs: 14-18); subsequently, it was compared by the NCBI website. The results showed that the 16S rDNA sequences of strains B37, A39, A41, A45 and A46 were respectively associated with Enterobacter cloacae subsp.cloacae ATCC 13047, Pseudomonas sp. BF-2, Pseudomonas sp. HR 26, Pseudomonas sp. BF-2, The 16S rDNA sequence similarity of Pseudomonas sp.HR 26 was 99%, 99%, 100%, 99%, and 99%, respectively. It is pointed out from the past literature that the strain similarity is more than 97%, and the strain is the same strain (Gevers et al., 2005). Therefore, the strain B37 is Enterobacter cloacae , while A39, A45, A41 and A46. All are Pseudomonas sp. (Pseudomonas). The 16S rDNA sequence of the five strains was also sequenced by the clustalw tool software. The A39 and A46 strains were similar; the B37 strain was similar to the other four strains. The relationship is far away. Therefore, the strain characteristics test will be carried out by following the three strains B37, A45 and A46.
B37-16S rDNA之序列(SEQ ID NO:14)如下: The sequence of B37-16S rDNA (SEQ ID NO: 14) is as follows:
A39-16S rDNA之序列(SEQ ID NO:15)如下: The sequence of A39-16S rDNA (SEQ ID NO: 15) is as follows:
A41-16S rDNA之序列(SEQ ID NO:16)如下: The sequence of A41-16S rDNA (SEQ ID NO: 16) is as follows:
A45-16S rDNA之序列(SEQ ID NO:17)如下: The sequence of A45-16S rDNA (SEQ ID NO: 17) is as follows:
A46-16S rDNA之序列(SEQ ID NO:18)如下: The sequence of A46-16S rDNA (SEQ ID NO: 18) is as follows:
(七)耐汞菌的生長特性測試 (7) Growth characteristics test of mercury-resistant bacteria
(1)耐鹽度測試 (1) Salt tolerance test
將所篩出的菌株B37、A45與A46培養在NB培養液一天後,將菌液吸光值(OD 600nm)調整到0.8後接種50μl在含有不同鹽度重量比例(0.5%,1%,2%,3.5%,4%,5%,6%)的50ml NB培養液中,並在前0~36小時區間內每2小時、36~72小時區間內每4小時、72~108小時區間內每8小時,分別進行測吸光值(OD 600nm),以製作生長曲線來觀察細菌的生長情形。 The strains B37, A45 and A46 which were screened were cultured in NB medium for one day, and the absorbance (OD 600nm) of the bacteria solution was adjusted to 0.8, and then 50 μl was inoculated with a weight ratio of different salinity (0.5%, 1%, 2%). , 3.5%, 4%, 5%, 6%) in 50ml NB medium, and every 4 hours, 36~72 hours in the interval of 0~36 hours every 4 hours, 72~108 hours At 8 hours, the absorbance (OD 600 nm) was measured separately to prepare a growth curve to observe the growth of the bacteria.
請參照第1A及1B圖所示,其揭示B37菌株耐鹽度測試的結果,其中含鹽濃度0.5%是NB培養液本身的鹽濃度,其他鹽濃度是藉由添加NaCl所達到的,而從圖中B37菌株在不同鹽濃度生長曲線結果可以看 出,B37菌株在含鹽1%與2%時對其生長是沒有太大的影響的,菌株的生長曲線與不添加NaCl的0.5%幾乎相同,生長的延遲期(lag phase)並沒有延長,OD 600nm最大吸光值都可達到大約1.4。而在鹽度3.5%之後延遲期會開始有延長的現象,代表菌株需要更長的時間來適應環境,再進入到對數生長期(log phase)大量複製生長。菌株在鹽度3.5%、4%、5%時生長曲線趨勢類似,大約都在4~6小時之間進入到對數生長期,而OD 600nm最大吸光值都可達到大約1.3。當鹽度到了6%時開始對B37菌株生長有明顯的抑制,菌株延遲期大幅延長,大約在10小時才進入到對數生長期,而且菌株生長最高濃度明顯下降,OD 600nm最大吸光值只能達到大約1.2。由以上結果可以顯示出B37菌株的鹽耐受性良好,在0.5%~5%鹽濃度時生長並沒有被明顯的抑制,直到鹽濃度到了6%時才開始受到抑制。 Please refer to the figures 1A and 1B, which reveal the results of the salt tolerance test of B37 strain, wherein the salt concentration of 0.5% is the salt concentration of the NB culture solution itself, and the other salt concentration is achieved by adding NaCl, and In the figure, the growth curve of B37 strain in different salt concentrations can be seen. The B37 strain had no significant effect on its growth when it contained 1% and 2% salt. The growth curve of the strain was almost the same as 0.5% without NaCl, and the lag phase of growth was not prolonged. The maximum absorbance of OD 600nm can reach about 1.4. The delay period begins to increase after the salinity of 3.5%, which means that the strain takes longer to adapt to the environment and then enters the log phase for large-scale replication growth. The growth curve of the strains was similar at salinity of 3.5%, 4%, and 5%, and the logarithmic growth phase was entered between about 4 and 6 hours, and the maximum absorbance of OD 600nm was about 1.3. When the salinity reached 6%, the growth of B37 strain was obviously inhibited, the delay period of the strain was greatly prolonged, and the logarithmic growth phase was entered in about 10 hours, and the highest concentration of strain growth was significantly decreased. The maximum absorbance of OD 600nm could only be reached. About 1.2. From the above results, it can be shown that the salt tolerance of the B37 strain is good, and growth at 0.5% to 5% salt concentration is not significantly inhibited until the salt concentration reaches 6%.
請參照第2A及2B圖所示,其揭示A45菌株耐鹽性測試結果,由圖中菌株的生長曲線顯示出在鹽度1%時並不會限制菌株生長,生長曲線和鹽度0.5%時是相似的,延遲期並沒有延長,而OD 600nm最大吸光值可達到大約1.2左右,比在鹽度0.5%最大吸光值1.1還要高。另外從結果圖中也可以看出在鹽濃度0.5%與1%時雖然菌株進入對數生長期的時間類似,但是在0.5%時菌株會更快的進入到死亡期(death phase)。而在鹽濃度2%時,菌株生長些微的受到抑制,約比在鹽濃度0.5%晚了2個小時才由延遲期進入到對數生長期,但菌株最高吸光值還是可以達到大約1.2左右,高於鹽度0.5%的1.1。在鹽濃度3.5%、4%、5%時菌株生長明顯的受到抑制,分別在約14、22、42小時才由延遲期進入到對數生長期,其中在鹽濃度3.5%與4%時菌株的吸光值最高還是能夠達到1.2,都高於鹽濃度0.5%的1.1,直到鹽濃度5%菌株最高的吸光值才低於1.1。而鹽濃度6%對菌株生長有強烈的抑制現象,菌株一直到了100小時才開始有生長的情形。由以上結果顯示出A45菌株能夠耐受一定的鹽濃度,在適應期延遲期結束後,在鹽濃度4%吸光值還是能達到1.2高於鹽濃度0.5%時的1.1,也顯示出A45菌株需要略高的鹽濃度(1%)生長會比較良好。 Please refer to the 2A and 2B graphs, which reveal the salt tolerance test results of the A45 strain. The growth curve of the strain in the figure shows that when the salinity is 1%, the growth of the strain is not restricted, and the growth curve and salinity are 0.5%. It is similar, the delay period is not extended, and the maximum absorbance of OD 600nm can reach about 1.2, which is higher than the maximum absorbance of 1.1 at a salinity of 0.5%. In addition, it can be seen from the results graph that although the salt enters the logarithmic growth phase at a salt concentration of 0.5% and 1%, the strain enters the death phase more quickly at 0.5%. At a salt concentration of 2%, the growth of the strain was slightly inhibited, and it was about 2 hours later than the salt concentration of 0.5%. The delayed growth period entered the logarithmic growth phase, but the highest absorbance of the strain could still reach about 1.2 or so. At a salinity of 0.5% of 1.1. At the salt concentration of 3.5%, 4%, 5%, the growth of the strain was significantly inhibited, and the lag phase entered the logarithmic growth phase at about 14, 22, and 42 hours, respectively, and the strain was at the salt concentration of 3.5% and 4%. The highest absorbance value can still reach 1.2, which is higher than the salt concentration of 0.5% of 1.1, until the highest absorbance of the salt concentration of 5% strain is less than 1.1. The salt concentration of 6% strongly inhibited the growth of the strain, and the strain did not begin to grow until 100 hours. From the above results, it was shown that the A45 strain can tolerate a certain salt concentration. After the end of the lag phase of the adaptation period, the absorbance at 4% of the salt concentration can still reach 1.1 at 1.2% above the salt concentration of 0.5%, which also shows that the A45 strain needs A slightly higher salt concentration (1%) will grow better.
請參照第3A及3B圖所示,其揭示A46菌株耐鹽性測試的生長曲線結果,由圖中的生長曲線結果可以看出A46菌株在鹽濃度1%時生 長狀態是最為良好,此時生長曲線的延遲期與0.5%的延遲期一致並沒有延長的情形,且其進入死亡期的時間也較0.5%來的短,OD 600nm最高吸光值可達到1.2左右。在鹽濃度2%時菌株的生長開始些微受到影響,延遲期持續大約8小時才開始進入對數生長期,而OD 600nm最高吸光值還是能達到1.1左右。當鹽濃度為3.5%、4%、5%時,菌株的生長開始明顯的受到抑制,分別在大約24、34、64小時才由延遲期進入到對數生長期,而最大OD 600nm分別可以達到大約1.2、1.2、1.1左右。而當鹽濃度6%時,菌株的生長受到顯著抑制,直到此測試結束(108小時),A46菌株都沒有生長的情形。由以上結果可以了解到A46菌株對鹽濃度有一定的耐受能力,雖然延遲期期間較長,但在3.5%海水鹽度下還是能夠生長的。 Please refer to the figures 3A and 3B, which reveal the growth curve results of the salt tolerance test of A46 strain. It can be seen from the growth curve results in the figure that the A46 strain is produced at a salt concentration of 1%. The long state is the best. At this time, the delay period of the growth curve is consistent with the 0.5% delay period, and the time to enter the death period is also shorter than 0.5%. The maximum absorption value of OD 600nm can reach 1.2 or so. . At the salt concentration of 2%, the growth of the strain began to be slightly affected, and the delay period lasted about 8 hours before it began to enter the logarithmic growth phase, while the maximum absorbance of OD 600nm was still about 1.1. When the salt concentration was 3.5%, 4%, 5%, the growth of the strain began to be significantly inhibited, and the delay period entered the logarithmic growth phase at about 24, 34, and 64 hours, respectively, and the maximum OD 600nm reached approximately 1.2, 1.2, 1.1 or so. When the salt concentration was 6%, the growth of the strain was significantly inhibited until the end of the test (108 hours), and the A46 strain did not grow. From the above results, it can be understood that the A46 strain has a certain tolerance to salt concentration, and although it is longer during the delay period, it can grow under 3.5% seawater salinity.
由耐鹽度測試的結果顯示出這B37、A45與A46三株菌株其對於鹽度都有一定的耐受能力,耐鹽度能力由強到弱分別為B37最強、A45次之、最弱的為A46菌株,但三菌株都能夠在海水鹽度3.5%下生長,應都能夠適應現地場址的鹽濃度。 The results of salt tolerance test showed that the three strains B37, A45 and A46 had certain tolerance to salinity. The salt tolerance ability was strongest to weakest, respectively, B37 was the strongest, A45 was the second, and the weakest was For the A46 strain, but all three strains can grow at a seawater salinity of 3.5%, they should be able to adapt to the salt concentration of the local site.
(2)耐汞能力測試 (2) Mercury resistance test
將所篩出的菌株B37、A45與A46培養在含有10ppm Hg2+的NB培養液中1天後,將菌液吸光值(OD 600nm)調整到0.8後接種50μl在含有不同汞重量濃度(0,20,40,60,80,100,150,200ppm)的50mlNB培養液中,並在0~24小時區間內每2小時、24~48小時區間內每4小時、48~72小時區間內每8小時,進行測吸光值(OD 600nm),製作出生長曲線來觀察細菌的生長情形。 The strains B37, A45 and A46 which were screened were cultured in NB medium containing 10 ppm Hg 2+ for 1 day, and the absorbance (OD 600 nm) of the bacteria solution was adjusted to 0.8, and then 50 μl was inoculated to contain different concentrations of mercury (0 , 20, 40, 60, 80, 100, 150, 200 ppm) in 50 ml NB medium, and every 8 hours, every 4 hours, 48 to 48 hours in the interval of 0 to 24 hours, every 8 hours, every 8 hours The absorbance (OD 600 nm) was used to prepare a growth curve to observe the growth of the bacteria.
請參照第4A及4B圖所示,其揭示B37菌株汞耐受性測試的結果,由圖中生長曲線的結果可以得知,20ppm汞濃度下對菌株的生長有些微的抑制,生長曲線從延遲期進入到對數生長期的時間比0ppm延遲2個小時,但菌株還是能夠生長,OD 600nm最大吸光值約為1.3,與0ppm最大吸光值1.376相近。而當汞濃度到達40ppm與60ppm時對菌株的生長開始有了明顯的抑制,菌株分別於14與18小時才由延遲期進入到對數生長期,而OD 600nm之最高吸光值仍可達到約1.5。在80ppm與100ppm的汞濃度下,菌株生長所被抑制的效果相近,同樣在約26小時進入到對數 生長期,生長情形相似。而當汞濃度來到150ppm與200ppm時,菌株的生長完全受到抑制。由以上結果顯示B37菌株對於汞有一定的耐受性,最高可達100ppm的汞濃度,應可耐受現地污染場址50ppm的汞濃度。 Please refer to Figures 4A and 4B for the results of the mercury tolerance test of B37 strain. It can be seen from the results of the growth curve in the figure that the growth of the strain is slightly inhibited at 20 ppm mercury concentration, and the growth curve is delayed. The period of entry into the logarithmic growth phase was delayed by 2 hours from 0 ppm, but the strain was able to grow, and the maximum absorbance of OD 600 nm was about 1.3, which was similar to the maximum absorbance of 0. When the concentration of mercury reached 40ppm and 60ppm, the growth of the strain was obviously inhibited. The strain entered the logarithmic growth phase from 14° to 18 hours, and the highest absorbance of OD 600nm could still reach about 1.5. At 80 ppm and 100 ppm mercury concentration, the growth of the strain was similarly inhibited, and the logarithm was also entered in about 26 hours. During the growth period, the growth situation is similar. When the mercury concentration came to 150 ppm and 200 ppm, the growth of the strain was completely inhibited. From the above results, it is shown that the B37 strain has a certain tolerance to mercury, and the mercury concentration of up to 100 ppm should be able to withstand the mercury concentration of 50 ppm of the in situ pollution site.
請參照第5A及5B圖所示,其揭示菌株A45的汞耐受性測試結果,由圖中生長曲線可以得知A45在汞濃度20ppm、40ppm與60ppm時耐受性良好,大約都在8小時由lag pahse進入到對數生長期,而OD 600nm吸光值最高都可以達到1.0以上。當汞濃度達到80ppm與100ppm時,對菌株生長開始有較明顯的抑制,到了分別在約10與12小時菌株才由延遲期進入到對數生長期,但菌株的OD 600nm最大吸光值還是可以達到1.2左右。汞濃度150ppm與200ppm時則完全抑制菌株的生長。由以上結果可以了解A45菌株的汞耐受性良好,在汞濃度100ppm還是能夠生長,應能耐受現地場址50ppm的汞濃度。 Please refer to the 5A and 5B graphs, which reveal the mercury tolerance test results of strain A45. It can be seen from the growth curve in the figure that A45 is well tolerated at mercury concentrations of 20 ppm, 40 ppm and 60 ppm, which are about 8 hours. From lag pahse to the logarithmic growth phase, the maximum absorbance of OD 600nm can reach 1.0 or more. When the concentration of mercury reached 80ppm and 100ppm, the growth of the strain began to be significantly inhibited. It took only about 10 and 12 hours for the strain to enter the logarithmic growth phase from the delayed phase, but the maximum absorbance of the strain at OD 600nm could still reach 1.2. about. When the mercury concentration is 150 ppm and 200 ppm, the growth of the strain is completely inhibited. From the above results, it can be understood that the A45 strain has good mercury tolerance, can grow at a mercury concentration of 100 ppm, and should be able to withstand the mercury concentration of 50 ppm at the local site.
請參照第6A及6B圖所示,其揭示A46菌株的汞耐受性測試的結果,由圖中的生長曲線結果顯示出A46菌株,其在汞濃度20ppm、40ppm、60ppm與80ppm下生長只有受到些微的抑制,大約在8小時就由延遲期進入對數生長期,而OD 600nm最大吸光值都可達到大約1.2。在汞濃度為100ppm時菌株生長開始明顯受到抑制,大約14小時才由延遲期進入對數生長期,但最後OD 600nm吸光值還是可以達到1.2以上。150pmm與200ppm的汞濃度時,則完全抑制菌株的生長。由以上結果顯示A46菌株對汞有一定耐受性,最高可以耐受100ppm汞濃度。 Please refer to Figures 6A and 6B, which reveal the results of the mercury tolerance test of the A46 strain. The results of the growth curve in the figure show that the A46 strain grows only at mercury concentrations of 20 ppm, 40 ppm, 60 ppm and 80 ppm. A slight inhibition, from the delay period to the logarithmic growth phase in about 8 hours, and the maximum absorbance of OD 600nm can reach about 1.2. At the mercury concentration of 100 ppm, the growth of the strain began to be significantly inhibited, and it took about 14 hours to enter the logarithmic growth phase from the delayed phase, but the absorbance at the OD 600 nm could still reach 1.2 or more. When the concentration of mercury is 150 pmm and 200 ppm, the growth of the strain is completely inhibited. From the above results, it is shown that the A46 strain is tolerant to mercury and can withstand a maximum concentration of 100 ppm.
對於此三菌株B37、A45與A46汞耐受性測試可以顯示此三菌株都能夠耐受100ppm的汞濃度,能夠在此濃度下生長,而其中B37菌株生長受到汞的影響是較大的,延遲期時間有明顯的延長,A45與A46相對於B37菌株是較不受汞影響的,A45與A46菌株各汞濃度的生長曲線也較為相似,由延遲期進入到對數生長期的時間大致一致。 For the three strains B37, A45 and A46 mercury tolerance test can show that the three strains can withstand 100ppm mercury concentration, can grow at this concentration, and the growth of B37 strain is affected by mercury is large, delayed The period of time was significantly prolonged. A45 and A46 were less affected by mercury than B37 strain. The growth curves of mercury concentration of A45 and A46 strains were similar, and the time from the delayed phase to the logarithmic growth phase was approximately the same.
(八)菌株還原汞離子能力的測試 (8) Testing of the ability of strains to reduce mercury ions
對三菌株B37、A45與A46分別以含10ppm Hg2+培養基20ml進行預培養18小時後,菌液加入滅菌的培養基將吸光值OD 600nm調整為0.8,之後接種5%到含汞的培養基中,培養基分別為NB、PMM與LB, 接種後含Hg2+濃度皆為60ppm。總共分成了六個組別,分別為:(1)B37單菌組、(2)A45單菌組、(3)A46單菌組、(4)三菌混合組(B37:A45:A46=1:1:1)、(5)取自原汞污染場址土壤混合菌之原土混合菌組S,以及(6)不加任何菌的無菌控制組,培養後分別在第0、1、2、3、6、9、12天取樣進行消化萃取(依行政院環境保護署環境檢驗所公告,水中汞檢測方法-冷蒸氣原子吸收光譜法,NIEA W330.52A)後,利用汞分析儀(HIRANUMA mercury analyzer HG-310)分析汞的濃度。各培養基成份如下:NB培養液(nutrient broth):動物組織消化物5g/L,NaCl 5g/L,牛肉萃取物1.5g/L,酵母萃取物1.5g/L。 After 18 hours of the three strains B37, A45 and A46, respectively, containing 20ml 10ppm Hg 2+ medium for pre-culture, the broth medium was added a sterilized OD 600nm absorbance value was adjusted to 0.8, then inoculated into 5% of mercury, The mediums were NB, PMM and LB, respectively, and the Hg 2+ concentration after inoculation was 60 ppm. A total of six groups were divided into: (1) B37 single bacteria group, (2) A45 single bacteria group, (3) A46 single bacteria group, and (4) three bacteria mixed group (B37: A45: A46=1). : 1:1), (5) from the original mixed bacteria group S of the soil mixed bacteria of the original mercury contaminated site, and (6) the aseptic control group without any bacteria, after the cultivation, respectively at 0, 1, 2 , 3,6,9,12 days sampling for digestion and extraction (according to the Environmental Protection Agency Environmental Protection Agency, the mercury detection method in water - cold vapor atomic absorption spectrometry, NIEA W330.52A), using mercury analyzer (HIRANUMA) Mercury analyzer HG-310) Analyze the concentration of mercury. The composition of each medium was as follows: NB culture liquid (nutrient broth): animal tissue digest 5 g / L, NaCl 5 g / L, beef extract 1.5 g / L, yeast extract 1.5 g / L.
PMM培養基(Pseudomonas mininal medium):7g的K2HPO4,3g的KH2PO4,0.5g的檸檬酸鈉,1g的MgSO4,7H2O,1g的(NH4)2SO4,4g的葡萄糖,1升的水,0.41g/L(0.41mg/ml)的亮氨酸、異亮氨酸和纈氨酸。 PMM medium ( Pseudomonas mininal medium): 7 g of K 2 HPO 4 , 3 g of KH 2 PO 4 , 0.5 g of sodium citrate, 1 g of MgSO 4 , 7H 2 O, 1 g of (NH 4 ) 2 SO 4 , 4 g Glucose, 1 liter of water, 0.41 g/L (0.41 mg/ml) of leucine, isoleucine and valine.
LB培養液(Luria-Bertani broth):酪蛋白酶水解物10g/L,酵母萃取物5g/L,NaCl 10g/L。 LB medium (Luria-Bertani broth): casein hydrolysate 10 g/L, yeast extract 5 g/L, NaCl 10 g/L.
請參照第7A圖所示,其揭示在含汞離子60ppm之NB培養液中Hg2+移除測試的結果。Hg2+被菌株還原後以元素態汞原子揮發到大氣中自然稀釋至環境,結果顯示六組中揮發汞效率最佳者為A45單菌組,其在12天的處理後可以使汞揮發54.4%,而其他組別B37單菌組、A46單菌組、三菌混合組與原土混合菌組之汞揮發率分別為34.0%、43.4%、42.0%與35.8%。由以上結果可以發現,菌株在移除一部份的汞離子後就維持穩定無法再處理剩餘汞離子。這可能是由於汞離子與NB培養液中的一些成份結合,使得培養基離子態的汞減少,而結合後的產物可能是由汞離子與氫硫基(R-SH)相互作用後所形成,因而此產物可能不直接作為汞還原酶的作用物(substrates),無法被還原成元素汞揮發經由空氣稀釋掉。另一方面可以發現不添加菌的控制組之汞濃度也有下降的情形,原因可能是培養基成份中的其他物質將離子汞還原成元素汞揮發到空氣中,或是汞離子吸附或擴散到容器壁上而造成的。 Please refer to Figure 7A for the results of the Hg 2+ removal test in a NB medium containing 60 ppm of mercury ions. After being reduced by the strain, Hg 2+ was naturally diluted to the environment by elemental mercury atoms volatilized into the atmosphere. The results showed that the best volatile mercury in the six groups was A45 single bacteria group, which could vulcanize mercury after 12 days of treatment. %, while the mercury volatilization rates of the other groups B37 single bacteria group, A46 single bacteria group, three bacteria mixed group and original soil mixed bacteria group were 34.0%, 43.4%, 42.0% and 35.8%, respectively. From the above results, it was found that the strain remained stable after removing a part of the mercury ions and could not process the remaining mercury ions. This may be due to the combination of mercury ions with some components in the NB culture solution, which reduces the ionic state of the mercury in the medium, and the combined product may be formed by the interaction of mercury ions with the thiol group (R-SH). This product may not directly act as a substrate for mercury reductase and cannot be reduced to elemental mercury volatilization and diluted by air. On the other hand, it can be found that the concentration of mercury in the control group without added bacteria also decreases, which may be caused by other substances in the medium component which reduce the ionic mercury to elemental mercury volatilized into the air, or the mercury ions adsorb or diffuse to the container wall. Caused by the above.
請參照第7B圖所示,其揭示在含汞離子60ppm之PMM培 養基中Hg2+移除測試的結果,結果顯示揮發汞效率最佳者為三菌混合組,其在12天的處理後可以使汞揮發89.0%,而A46單菌組的揮發效果次之可以揮發87.2%的汞離子,而其他組別B37單菌組、A45單菌組與原土混合菌組之汞揮發率分別為43.1%、28.1%與35.5%,這三組揮發汞的效率不佳可能是由於在含汞離子60ppm之PMM培養基中此三組別的菌生長情況不佳,菌液到了12天的採樣結束後都是呈澄清的狀態,因此沒有足夠菌量來揮發汞離子。另外可以發現不添加菌的控制組中汞濃度也有下降的情形,且下降幅度達62.1%。這可能是由於PMM培養基中含有磷酸鹽類(K2HPO4與KH2PO4),而汞離子可能會和磷酸鹽反應生成Hg3(PO4)2與HgHPO4,此兩種汞磷酸鹽的溶解度都不高,分別為1.4x10-8mol/L與2.8x10-7mol/L,在水中會產生白色沉澱,因此在檢測汞濃度時會無法測得沉澱的部份。 Please refer to Figure 7B, which reveals the results of the Hg 2+ removal test in PMM medium containing 60 ppm of mercury ions. The results show that the best efficiency of volatile mercury is the three bacteria mixed group, which can be treated after 12 days. The mercury volatilization rate was 89.0%, while the volatilization effect of the A46 single bacteria group could volatilize 87.2% of mercury ions, while the other group B37 single bacteria group, A45 single bacteria group and original soil mixed bacteria group had the mercury volatilization rate of 43.1 respectively. %, 28.1% and 35.5%. The inefficiency of these three groups of volatile mercury may be due to the poor growth of the three groups of bacteria in PMM medium containing 60 ppm of mercury ions. The bacteria liquid was collected after 12 days of sampling. It is in a clarified state, so there is not enough bacteria to volatilize mercury ions. In addition, it can be found that the concentration of mercury in the control group without added bacteria also decreased, and the decrease was 62.1%. This may be due to the presence of phosphates (K 2 HPO 4 and KH 2 PO 4 ) in the PMM medium, which may react with phosphate to form Hg 3 (PO 4 ) 2 and HgHPO 4 , both of which are The solubility is not high, 1.4x10 -8 mol/L and 2.8x10 -7 mol/L, respectively, and it will produce white precipitate in water, so the precipitated part cannot be detected when the mercury concentration is detected.
請參照第7C圖所示,其揭示在含汞離子60ppm之LB培養液中Hg2+移除測試的結果,結果顯示揮發汞效率最佳者為B37單菌組,其在12天處理後可以使汞揮發88.6%,而其他組別A45單菌組、A46單菌組、三菌混合組與原土混合菌組之汞揮發率分別為80.3%、86.2%、82.7%與69.4%。可以發現這些菌組在移除一部份的汞離子後就維持穩定無法再處理剩餘的汞離子。這情形和使用含汞離子60ppm之NB培養液組的測試結果類似,但剩除無法處理汞離子的量較NB培養液組的測試結果為少。此結果可能是汞離子與LB培養液中的一些成份結合,使得培養基離子態的汞減少,而結合後的產物可能為汞離子與氫硫基(R-SH)相互作用後所形成的,而此產物可能不直接作為汞還原酶的作用物,因此無法被還原成元素汞。另一方面,可以發現不添加菌的控制組中汞濃度也有下降的情形,與含汞離子60ppm之NB培養液組的測試結果類似,但使用LB培養液之汞濃度比使用NB培養液組下降還要來的多,原因可能是培養基成份中的其他物質將離子汞還原成元素汞揮發到空氣中,或是汞離子的吸附或擴散到容器壁上而造成的。 Please refer to Figure 7C, which reveals the results of the Hg 2+ removal test in LB medium containing 60 ppm of mercury ions. The results show that the best volatile mercury is B37 single bacteria group, which can be treated after 12 days. The mercury volatilization rate was 88.6%, while the mercury volatilization rates of other groups A45 single bacteria group, A46 single bacteria group, three bacteria mixed group and original soil mixed bacteria group were 80.3%, 86.2%, 82.7% and 69.4%, respectively. It can be found that these bacteria groups remain stable after removing a part of the mercury ions and can no longer handle the remaining mercury ions. This case is similar to the test results using the NB culture solution group containing 60 ppm of mercury ions, but the amount of mercury ions that cannot be treated is less than that of the NB culture solution group. This result may be that mercury ions are combined with some components in the LB culture solution to reduce the ionic state of the mercury in the medium, and the combined product may be formed by the interaction of mercury ions with the hydrogenthio group (R-SH). This product may not act directly as a substrate for mercury reductase and therefore cannot be reduced to elemental mercury. On the other hand, it can be found that the mercury concentration in the control group without added bacteria also decreased, similar to the test results of the NB culture solution group containing 60 ppm of mercury ions, but the mercury concentration in the LB culture solution was lower than that in the NB culture solution group. The reason for this is that the other substances in the medium component are reduced by the reduction of ionic mercury into elemental mercury volatilized into the air, or by the adsorption or diffusion of mercury ions onto the walls of the container.
從三種培養基測試菌株移除汞離子能力的結果中可以顯示移除效果最好的為使用PMM培養基中的三菌混合組,其可以移除掉89.0%汞離子,但因為此培養基會有培養基成份與汞離子反應形成沉澱的問題存 在,所以選擇LB培養基來培養菌株移除汞離子污染是較客觀可行的。而在LB培養基中移除汞離子效率最高的B37單菌組則可以移除88.6%的汞離子。由以上比較,可以了解所篩選出的菌株已有一定移除汞離子的能力,而如果要再加強的話可改用生物反應器培養測試。 The results of the ability to remove mercury ions from the three medium test strains showed that the best removal effect was the use of the three bacteria mixed group in the PMM medium, which removed 89.0% of the mercury ions, but because the medium had the medium composition The problem of reacting with mercury ions to form a precipitate Therefore, it is more objective and feasible to select LB medium to culture strains to remove mercury ion contamination. The B37 single bacteria group with the highest efficiency of removing mercury ions in LB medium can remove 88.6% of mercury ions. From the above comparison, it can be understood that the selected strain has a certain ability to remove mercury ions, and if it is to be strengthened, the bioreactor culture test can be used instead.
根據上述實驗結果,在本發明之一實施例中,本發明可提供一種汞污染生物整治用製劑,其包含:至少一種菌株,篩選自台南中石化安順廠舊場址之土壤,並具有將離子汞還原成元素汞能力,以及能在3.5wt%海水鹽度下維持生長,該菌株係選自陰溝腸桿菌(Enterobacter cloacae B37)、假單胞菌屬(Pseudomonas sp.A45)或假單胞菌屬(Pseudomonas sp.A46),該些經由上述實驗篩選出之菌株依序以寄存編號BCRC 910603、BCRC 910604及BCRC 910605寄存於食品工業發展研究所的生物資源保存及研究中心(BCRC of FIRDI);另外,在另一實施例中,該汞污染生物整治用製劑也可包含數種菌株,並選擇同時使用上述三菌株。此時,該陰溝腸桿菌(Enterobacter cloacae B37)、假單胞菌屬(Pseudomonas sp.A45)及假單胞菌屬(Pseudomonas sp.A46)之混合比例可以是1至10:1至10:1至10,較佳為1至5:1至5:1至5,特別是1至2:1至2:1至2,例如為1:1:1。 According to the above experimental results, in one embodiment of the present invention, the present invention provides a mercury-contaminated bioremediation preparation comprising: at least one strain, which is screened from the soil of the old site of the Anshun Plant of Tainan Sinopec, and has ionic mercury capacity reduced to elemental mercury, as well as to maintain growth at salinity 3.5wt%, the strain is selected from Enterobacter cloacae (Enterobacter cloacae B37), Pseudomonas (Pseudomonas sp.A45) or Pseudomonas (Pseudomonas sp.A46), which filter out some of the experiments via the strain sequence number to register BCRC 910603, BCRC 910604 and BCRC 910605 Storage biological resources conservation and research center Institute for food industry development (BCRC of FIRDI); in addition In another embodiment, the mercury-contaminated bioremediation preparation may also comprise several strains, and the three strains described above are selected to be used at the same time. At this time, Enterobacter cloacae (Enterobacter cloacae B37), Pseudomonas (Pseudomonas sp.A45) and Pseudomonas (Pseudomonas sp.A46) the mixing ratio may be 1 to 10: 1 to 10: 1 Up to 10, preferably 1 to 5:1 to 5:1 to 5, particularly 1 to 2:1 to 2:1 to 2, for example 1:1:1.
另外,本發明也提供一種汞污染生物整治用製劑之使用方法,其包含:提供一種如上所述之汞污染生物整治用製劑;以及將該汞污染生物整治用製劑施加於台灣地區之一汞污染廠址,以進行現地生物整治。 In addition, the present invention also provides a method for using a mercury-contaminated bioremediation preparation, comprising: providing a mercury-contaminated biological remediation preparation as described above; and applying the mercury-contaminated bioremediation preparation to a mercury contamination in Taiwan The site is for local bioremediation.
根據本發明之一實施例,該汞污染生物整治用製劑可使用之受污染的介質可以是一液態或含水固態的環境介質,包含:地下水(groundwater)、廢水(waste water),或是含有地下水或廢水之土壤(soil)、污泥(sludge)或沉積物(sediment),且特別是鄰近海岸或河口的汞污染廠址環境介質。例如,該受污染的介質是選自於下列所構成的群組:飲用水源(例如井水)、漁業養殖池、工廠廢水、家庭污水、富含水份之工廠用地土壤、農業用地(例如水田、果園用地、放牧草地等)土壤以及污水處理廠的淤泥,且特別是選自鄰近海岸或河口者,例如為台南中石化安順廠舊場址(或附近)之海水、海岸溼地或鄰近地區富含海水之土壤。 According to an embodiment of the present invention, the contaminated medium usable by the mercury-contaminated bioremediation preparation may be a liquid or aqueous solid environment medium, including: groundwater, waste water, or groundwater containing Or soil, sludge or sediment of wastewater, and in particular mercury contaminated site environmental media adjacent to the coast or estuary. For example, the contaminated medium is selected from the group consisting of drinking water sources (eg, well water), fish culture ponds, factory wastewater, domestic sewage, water-rich plant land soil, agricultural land (eg, Soils in paddy fields, orchards, grazing grasslands, etc., and sludge from sewage treatment plants, especially those selected from adjacent coasts or estuaries, such as seawater, coastal wetlands or adjacent areas of the old site (or nearby) of Tainan Sinopec Anshun Plant (or nearby) Seawater-rich soil.
根據本發明之一實施例,該汞污染生物整治用製劑可選擇性含有對於微生物生長有益的營養物,例如:甘油(glycerol)、核黃素(riboflavin)、酪蛋白(casein)、聚蛋白腖(polypeptone)、肉萃取物(meat extract)、大豆餅(soybean cake)、酵母萃取物(yeast extract)、纖維素、葡萄糖、玉米萃取物(corn extract)、乳清粉末(whey powder)、澱粉、維生素[如噻胺(thiamine)、生物素(biotin)、菸鹼醯胺(nicotinic acid amide)或泛酸鈣(calcium panthotenate)],或是含有酵素,諸如澱粉酶(amylase)、蛋白酶(protease)及/或脂酶(lipase),但並不限於此。 According to an embodiment of the present invention, the mercury-contaminated bioremediation preparation may optionally contain nutrients beneficial to the growth of microorganisms, such as glycerol, riboflavin, casein, polypeptone ( Polypeptone), meat extract, soybean cake, yeast extract, cellulose, glucose, corn extract, whey powder, starch, vitamins [such as thiamine, biotin, nicotinic acid amide or calcium panthotenate], or containing enzymes such as amylase, protease and/ Or lipase, but not limited to this.
根據本發明之一實施例,該汞污染生物整治用製劑可利用已知技術被製造成一適合使用的形式,其包括:培養液(culture solution)、懸浮液、顆粒體(granules)、乾燥粉末、錠劑(tablet)、丸劑(pill)、膠囊(capsules)、濃漿(slurry)及/或其相似之物,但並不限於此。此外,必要時,該汞污染生物整治用製劑也可以被固著(immobilized)在一不可溶的支撐物(insoluble support)上而被使用,例如使用於污水處理廠中處理含汞污水。 According to an embodiment of the present invention, the mercury-contaminated bioremediation preparation can be manufactured into a form suitable for use by a known technique, including: a culture solution, a suspension, granules, a dry powder, Tablets, pills, capsules, slurries, and/or the like, but are not limited thereto. Further, if necessary, the mercury-contaminated bioremediation preparation may be used by being immobilized on an insoluble support, for example, in a sewage treatment plant for treating mercury-containing sewage.
根據本發明之一實施例,該汞污染生物整治用製劑也可進一步包含有一生物可相容的載體(biocompatible carrier)。例如,在一實施例中,該汞污染生物整治用製劑中的一至三種特定菌株可被包埋(entrapped in)在該生物可相容的載體內。此時,該生物可相容的載體包含:矽膠(silica gel)、澱粉、瓊脂、幾丁質(chitin)、幾丁聚糖(chitosan)、聚乙烯醇(polyvinyl alcohol)、藻酸(alginic acid)、聚丙烯醯胺(polyacrylamide)、鹿角菜膠(carrageenan)、瓊脂糖(agarose)、明膠(gelatin)、纖維素、醋酸纖維素(cellulose acetate)、聚葡萄糖(dextran)及膠原蛋白(collagen)中的一種或以上,但並不限於此。在另一實施例中,該汞污染生物整治用製劑中的一至三種特定菌株亦可以被披覆(coated on)在該生物可相容的載體顆粒上。此時,該生物可相容的載體顆粒包含:玻璃、陶瓷(ceramic)、金屬氧化物(metal oxide)、活性碳(activated carbon)、高嶺石(kaolinite)、皂土(bentonite)、沸石(zeolite)、鋁(alumina)、無煙煤(anthracite)、戊二醛(glutaraldehyde)、聚丙烯酸(polyacrylic acid)、聚胺甲酸酯(polyurethane)、聚氯乙烯(polyvinyl chloride)、離子交換樹脂(ion exchange resin)、環氧樹脂(epoxy resin)、光塑性樹脂(photosetting resin)、聚酯(polyester)及聚苯乙烯(polystyrene)中的一種或以上,但並不限於此。 According to an embodiment of the present invention, the mercury-contaminated bioremediation preparation may further comprise a biocompatible carrier. For example, in one embodiment, one to three specific strains of the mercury-contaminated bioremediation formulation can be entrapped in the biocompatible carrier. At this time, the biocompatible carrier comprises: silica gel, starch, agar, chitin, chitosan, polyvinyl alcohol, alginic acid. ), polyacrylamide, carrageenan, agarose, gelatin, cellulose, cellulose acetate, dextran, and collagen One or more of them, but is not limited thereto. In another embodiment, one or three specific strains of the mercury-contaminated bioremediation formulation may also be coated on the biocompatible carrier particles. At this time, the biocompatible carrier particles comprise: glass, ceramic, metal oxide, activated carbon, kaolinite, bentonite, zeolite (zeolite) ), aluminum, anthracite, glutaraldehyde, polyacrylic acid, polyurethane, polyvinyl chloride, ion exchange resin ), epoxy resin, photoplastic resin (photosetting) One or more of resin, polyester, and polystyrene, but is not limited thereto.
值得注意的是,本領域技術人員應當理解,即使是同種菌株之不同品系(strain),其在生理特性及功能仍存在有相當大的差異,因此本發明之保護範圍僅限於經由上述實驗方式在特定場址位置篩選出之台灣本土菌株B37、A45、A46之單獨使用或複合使用,亦即本發明保護範圍並不及於經由不同實驗方式及/或由不同場址位置篩選出之同種菌株的不同品系,特別是不及於國外不同場址位置篩選出之同種菌株的不同品系,於此合先敘明。 It should be noted that those skilled in the art should understand that even if different strains of the same strain have considerable differences in physiological characteristics and functions, the scope of protection of the present invention is limited to the above experimental methods. The use of Taiwan native strains B37, A45, and A46, which are screened at specific site locations, alone or in combination, that is, the scope of protection of the present invention is not different from that of the same strains screened by different experimental methods and/or by different site locations. The strains, especially the different strains of the same strains that were not screened at different sites in foreign countries, are described first.
雖然本發明已以較佳實施例揭露,然其並非用以限制本發明,任何熟習此項技藝之人士,在不脫離本發明之精神和範圍內,當可作各種更動與修飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 The present invention has been disclosed in its preferred embodiments, and is not intended to limit the invention, and the present invention may be modified and modified without departing from the spirit and scope of the invention. The scope of protection is subject to the definition of the scope of the patent application.
國內寄存資訊【請依寄存機構、日期、號碼順序註記】 Domestic registration information [please note according to the registration authority, date, number order]
食品工業發展研究所 2013-12-31 BCRC 910603 Food Industry Development Institute 2013-12-31 BCRC 910603
食品工業發展研究所 2013-12-31 BCRC 910604 Food Industry Development Institute 2013-12-31 BCRC 910604
食品工業發展研究所 2013-12-31 BCRC 910603 Food Industry Development Institute 2013-12-31 BCRC 910603
Organization Applicant Organization Applicant
<110> OrganizationName:National Sun Yat-sen University <110> OrganizationName: National Sun Yat-sen University
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:21 <211> Length: 21
SequenceName:A1s-n.F forward primer(SEQ ID NO 1) SequenceName: A1s-n.F forward primer (SEQ ID NO 1)
Sequehce Sequehce
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:22 <211> Length: 22
SequenceName:A5-n.R reverse primer(SEQ ID NO 2) SequenceName: A5-n.R reverse primer (SEQ ID NO 2)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:57 <211> Length: 57
SequenceName:968fgc forward primer(SEQ ID NO 3) SequenceName: 968fgc forward primer (SEQ ID NO 3)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:17 <211> Length: 17
SequenceName:1401r reverse primer(SEQ ID NO 4) SequenceName: 1401r reverse primer (SEQ ID NO 4)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:286 <211> Length: 286
SequenceName:B37-merA gene(SEQ ID NO 5) SequenceName: B37-merA gene (SEQ ID NO 5)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:285 <211> Length: 285
SequenceName:A39-merA gene(SEQ ID NO 6) SequenceName: A39-merA gene (SEQ ID NO 6)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:285 <211> Length: 285
SequenceName:A41-merA gene(SEQ ID NO 7) SequenceName: A41-merA gene (SEQ ID NO 7)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:285 <211> Length: 285
SequenceName:A45-merA gene(SEQ ID NO 8) SequenceName: A45-merA gene (SEQ ID NO 8)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:284 <211> Length: 284
SequenceName:A46-merA gene(SEQ ID NO 9) SequenceName: A46-merA gene (SEQ ID NO 9)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:19 <211> Length: 19
SequenceName:9f forward primer(SEQ ID NO 10) SequenceName: 9f forward primer (SEQ ID NO 10)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:20 <211> Length: 20
SequenceName:1525r reverse primer(SEQ ID NO 11) SequenceName: 1525r reverse primer (SEQ ID NO 11)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:20 <211> Length: 20
SequenceName:T7 forward primer(SEQ ID NO 12) SequenceName: T7 forward primer (SEQ ID NO 12)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:19 <211> Length: 19
SequenceName:SP6 reverse primer(SEQ ID NO 13) SequenceName: SP6 reverse primer (SEQ ID NO 13)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:1534 <211> Length: 1534
SequenceName:B37-16S rDNA(SEQ ID NO 14) SequenceName: B37-16S rDNA (SEQ ID NO 14)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:1531 <211> Length: 1531
SequenceName:A39-16S rDNA(SEQ ID NO 15) SequenceName: A39-16S rDNA (SEQ ID NO 15)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:1516 <211> Length: 1516
SequenceName:A41-16S rDNA(SEQ ID NO 16) SequenceName: A41-16S rDNA (SEQ ID NO 16)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:1531 <211> Length: 1531
SequenceName:A45-16S rDNA(SEQ ID NO 17) SequenceName: A45-16S rDNA (SEQ ID NO 17)
Sequence Sequence
<213> OrganismName:Artificial <213> OrganismName: Artificial
<400> PreSequenceString:
<212> Type:DNA <212> Type:DNA
<211> Length:1530 <211> Length: 1530
SequenceName:A46-16S rDNA(SEQ ID NO 18) SequenceName: A46-16S rDNA (SEQ ID NO 18)
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103101413A TWI623499B (en) | 2014-01-15 | 2014-01-15 | Bioremediation preparation for mercuric pollution and using method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103101413A TWI623499B (en) | 2014-01-15 | 2014-01-15 | Bioremediation preparation for mercuric pollution and using method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201527227A TW201527227A (en) | 2015-07-16 |
TWI623499B true TWI623499B (en) | 2018-05-11 |
Family
ID=54198081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103101413A TWI623499B (en) | 2014-01-15 | 2014-01-15 | Bioremediation preparation for mercuric pollution and using method thereof |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI623499B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109354307B (en) * | 2018-11-01 | 2021-10-01 | 山东尚科环境工程有限公司 | In-situ purification black and odorous water body treatment method and treatment device thereof |
CN113957013B (en) * | 2021-11-18 | 2023-03-14 | 云南大学 | Pseudomonas, microbial inoculum containing pseudomonas, preparation method and application thereof |
CN114181841A (en) * | 2021-11-24 | 2022-03-15 | 浙江大学 | Fungus and biological agent for treating mercury pollution, application of fungus and biological agent, mercury removal method and method for identifying fungus with mercury pollution treatment capability |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1683518A (en) * | 2005-01-06 | 2005-10-19 | 福建医科大学 | High anti-mercury offensive smell pseudomonas strain CHY-7 and use in treating mercury pollution |
CN102191191B (en) * | 2010-12-20 | 2012-11-07 | 中南大学 | Heavy metal-tolerant bacterial strain and application thereof |
CN102373161B (en) * | 2010-08-06 | 2013-08-07 | 中国科学院烟台海岸带研究所 | Bacterium for reducing mercury pollution in seawater and application thereof |
-
2014
- 2014-01-15 TW TW103101413A patent/TWI623499B/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1683518A (en) * | 2005-01-06 | 2005-10-19 | 福建医科大学 | High anti-mercury offensive smell pseudomonas strain CHY-7 and use in treating mercury pollution |
CN102373161B (en) * | 2010-08-06 | 2013-08-07 | 中国科学院烟台海岸带研究所 | Bacterium for reducing mercury pollution in seawater and application thereof |
CN102191191B (en) * | 2010-12-20 | 2012-11-07 | 中南大学 | Heavy metal-tolerant bacterial strain and application thereof |
Non-Patent Citations (1)
Title |
---|
Sinha A et al, "Mercury bioremediation by mercury accumulatin Enterobacter sp. Cells and its alginate immobilized application", Biodegradation(2012)23:25-34 * |
Also Published As
Publication number | Publication date |
---|---|
TW201527227A (en) | 2015-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Talha et al. | Bioremediation of Congo red dye in immobilized batch and continuous packed bed bioreactor by Brevibacillus parabrevis using coconut shell bio-char | |
Kang et al. | Bioremediation of lead by ureolytic bacteria isolated from soil at abandoned metal mines in South Korea | |
Errasquın et al. | Tolerance and uptake of heavy metals by Trichoderma atroviride isolated from sludge | |
Ito et al. | Biological oxidation of arsenite in synthetic groundwater using immobilised bacteria | |
Rodrigues et al. | Chitin as a substrate for the biostimulation of sulfate-reducing bacteria in the treatment of mine-impacted water (MIW) | |
Jebelli et al. | Isolation and identification of indigenous prokaryotic bacteria from arsenic-contaminated water resources and their impact on arsenic transformation | |
US20120276615A1 (en) | Recombinant bacterium capable of removing mercury (ii) species, cadmium (ii) and copper (ii) in presence of other heavy metals from polluted sites, product for the bioremediation, process of obtaining the product and method of bioremediation | |
CN106635867B (en) | Halophilic Bacillus and its application | |
Mathivanan et al. | Tolerance and biosorption of cadmium (II) ions by highly cadmium resistant bacteria isolated from industrially polluted estuarine environment | |
Arakawa et al. | Growth stimulation of iodide-oxidizing α-Proteobacteria in iodide-rich environments | |
Yi et al. | An efficient Chlorella sp.-Cupriavidus necator microcosm for phenol degradation and its cooperation mechanism | |
Nguyen et al. | Kinetics of microbial selenite reduction by novel bacteria isolated from activated sludge | |
TWI623499B (en) | Bioremediation preparation for mercuric pollution and using method thereof | |
Werkneh et al. | Simultaneous removal of selenite and phenol from wastewater in an upflow fungal pellet bioreactor | |
Saleem et al. | Arsenic respiration and detoxification by purple non-sulphur bacteria under anaerobic conditions | |
Ayad et al. | Tolerance of Trichoderma sp. to heavy metals and its antifungal activity in Algerian marine environment | |
Tang et al. | Biological characteristics and oxidation mechanism of a new manganese-oxidizing bacteria FM-2 | |
CN115369060B (en) | Triazolone degrading bacteria and microbial inoculum | |
Villegas et al. | Removal of heavy metals from aqueous solution by biofilm-forming bacteria isolated from mined-out soil in Mogpog, Marinduque, Philippines | |
Varmazyar | Removal of mercuric chloride by a mercury resistant Pseudomonas putida strain | |
CN113755371B (en) | Strain A.seifertigii P52-1 and application thereof in degradation of polychlorinated biphenyl | |
CN113583899B (en) | Sphingosine strain JT-M9-H as polycyclic aromatic hydrocarbon degrading strain | |
Rehman et al. | Copper tolerant yeast, Candida tropicalis, isolated from industrial effluents: Its potential use in wastewater treatment | |
CN115851450A (en) | Cladosporium tenuissima NXY8, mycelial ball and application thereof in high-salt wastewater treatment | |
JP4088690B2 (en) | New microorganisms and methods for removing arsenic by microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |